A look into the Expert Panels Review By Leigh

Slides:



Advertisements
Similar presentations
Chapter 28 Promotion and Place Name 12 SAM.
Advertisements

2 emcdda.europa.eu European drug report package A comprehensive analysis on the drugs problem in Europe.
The Health Implications of Raising the Minimum Age for Purchasing Tobacco Products Eric N. Lindblom Director, Office of Policy Center for Tobacco Products,
Synthetic Drug Awareness. LAW ENFORCEMENT SENSITIVE/FOUO2 BLUF Consistent trend in use across DoN  CONUS / OCONUS  Navy / Marine Corps Similar trend.
Online Sales and Use of Synthetic Cannabinoids Preliminary findings from a Norwegian study Ola Røed Bilgrei Anne Line Bretteville-Jensen SIRUS.
The War on Drugs: Methamphetamine, Public Health and Crime Carlos Dobkin, Nancy Nicosia.
Dr Richard Stevenson. Confusing terminology “Designer Drugs” “Bath Salts” “Legal Highs” “Psychoactive drugs, newly available in the UK, which are not.
Bath Salts. INTRODUCTION / OVERVIEW The Florida Department of Law Enforcement (FDLE) is providing the following situational awareness brief addressing.
New Psychoactive Substances A BRIEF INSIGHT BY LEIGH WESTMORE.
Massmart Presentation on Medicines and Related Substances Amendment Bill, 2008 Presentation by Graham Rebello Massmart Channel Executive.
Legal Highs- What is it all about? Sinead O’Mahony Carey Substance Misuse Service HSE 2010 Sinead O.Mahony Carey Substance Misuse Service HSE 2010.
THE ROLE OF ATTITUDES AND PRACTICES OF THE ENVIRONMENT AND TEACHERS’ KNOWLEDGE’S ABOUT TOBACCO USE AMONG ADOLESCENTS AUTHORS: Dr. Nazane Breca, Dr. Idriz.
TOTAL POLICING New Psychoactive Substances – Public protection and law enforcement Ian Goldsborough Metropolitan Police Drugs Directorate (SC&O3 Specialist.
CJ411-Chat 9 By: Amy Ng, ABD. Objectives Unit Reminders Decriminalization Harm reduction.
Harm Reduction.
Chapter 4 Drugs and the Law.
P ROBLEMS WITH N EW P SYCHOACTIVE S UBSTANCES AND HOW TO DEAL WITH IT Roman Gabrhelík Serbia, 2013.
Polydrug use challenges – European experience International Conference: New trends in drug use: facts and solutions, Parliament of the Republic of Vilnius.
INTRODUCTION TO RA.
Annual report 2010: the state of the drugs problem in Europe.
Trends and developments Selected trends and some insights in prevention Vilnius, 12 November 2014 Roland Simon.
Overview of Drug Control in Foreign Countries. Drug Control in EU A. Policy Trends ■ Decriminalisation of possession of small amount of drugs for personal.
Topic 4 Marketing International Marketing and E-Commerce.
Synthetic cannabinoid agonists (SCRAs) Harry Shapiro DrugScope.
Competencies Define consumer terms. Define agencies and publications that deal with consumer protection. Recognize what it means to be a “wise consumer.”
Social work and substance use policy Dr Sarah Galvani University of Bedfordshire Chair, BASW SIG in Alcohol and other Drugs.
Paul Griffiths and Roland Simon Wrap-up presentation What has the EMCDDA learned ?
NPS Symposium Charles Berry House Tuesday November 3 rd 2015 Dr Rob Hampton
Citywide Drugs Crisis Campaign 20 years experience of Community Involvement – Key Lessons for the next National Drugs Strategy 12 TH NOVEMBER 2015.
Preventing drug diversion: Principles and concepts International Pain Policy Fellowship August 7, 2012 David E. Joranson Distinguished Scientist, Founder.
Should marijuana be legalized?. How and When this controversy started  Use of marijuana became a problem in the 1930s in the U.S.  1937: Laws passed.
The Danish Textile Panel Established in 1999 by the Danish EPA The purpose is to focus on textiles’ environmental impact in a lifecycle perspective by.
4/20/2012 IUGB BADI NATHANAEL. OUTLINE Introduction Key questions The different kinds of drugs Legalization of drugs Abuse of drugs Use of Drugs Conclusion.
First European conference on drug supply indicators, , Brussels – Feed-back Chloé Carpentier, Laurent Laniel, EMCDDA 33 rd meeting of the.
New Psychoactive Substances Presented by Barry James Forensic Scientist (Drugs) 15 th September 2015.
Psychoactive Substances Act 2016 Angela Scrutton Drugs Legislation Drugs and Alcohol Unit | Home Office.
Launch of the INCB Annual Reports March 2016.
NPS injecting harms and harm reduction. Psychoactive Substances Health Workshop Friday 4 th March 2016 Emma Hamilton A national resource of expertise on.
Crown Office and Procurator Fiscal Service Working Together to be the Best Tackling New Psychoactive Substances in Scotland Paul Miele – Procurator Fiscal.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.
Collaboration between the national EWS and treatment service providers in Hungary Anna Péterfi Hungarian National Focal Point TAIEX seminar Zagreb,
‘The War on Drugs: Failures, Impacts, and Alternatives, and the Future of Public Health’ Niamh Eastwood Release 15 November 2014.
New Psychoactive Substances: an overview of the evidence Isla Wallace, Social Researcher Drugs Research Team
NPS Intravenous Use in the UK: Current Situation and Experiences Catherine Crawford, UK Focal Point.
Addressing the Federal Legalization of Cannabis Briefing to Standing Committee on Priorities and Planning June 7, 2017.
Magali Martinez, Agnès Cadet-Taïrou TREND UNIT, OFDT
Tackling the challenge of NPS in Israel
Legal and Illegal Drugs
Public Health Implications of
Proposition 64 County Behavioral Health Directors Association
Addressing the Federal Legalization of Cannabis Briefing to Standing Committee on Priorities and Planning June 7, 2017.
The effectiveness and cost-effectiveness of alcohol control policies PHE Evidence Review 31st January 2017.
Bath Salts.
Proposition 64 County Behavioral Health Directors Association
The social epidemiology of alcohol and drug use among Israeli school-aged children: Recent developments and current challenges Prof. Yossi Harel-Fisch.
New Psychoactive Substances (NPS) in Deep Web Marketplaces (DWM):
Bath Salts.
May 8, 2018 Nova Scotia Law Enforcement Perspective
Políticas Públicas em Alcohol
Second European Conference on Addictive Behaviours and Dependencies
New Psychoactive Substances in Portugal
Competencies Define consumer terms.
Development of IAS policy
Drugs the law & government responses
January 2019 ROSC Seminar.
IMPROVING SCOTLAND’S HEALTH Rights, Respect and Recovery
Economic and Fiscal Considerations of Legalized Cannabis
Alcohol and Drug Policy Changes in Russia – 2019
Stakeholder Engagement Meeting
Risk Reduction on New Drugs,
Presentation transcript:

A look into the Expert Panels Review By Leigh

 NPS In context  Substances recap  Home Office Review  Nature and Challenge Of NPS  UK Response to date  Options to restrict  Wider implications  Conclusions  Questions Leigh Westmore

 Ecstasy/Cocaine replacement.  Mephedrone, MPDV, Benzo Fury, MDAI, ethylphenidate, methiopropamine, 3'- fluorophenmetrazine Prices vary from £9 for 0.5gm - £30 for 1gm Leigh Westmore

 ; NBOH-series. Methoxetamine (MXE) Diphenidine, methoxphenidine, AMT, aladin, LSZ Leigh Westmore

 Originally “spice” Online shops sell many Varieties. 1 shop recently selling 100 herbal incense products, ranging from £8 - £40 ) Leigh Westmore

 Panel assembled in December 2013 to look at the issue of NPS, wide range of areas such as law enforcement, medical, academia and Social Science.  The Panel defined NPS as: ‘ Psychoactive drugs, newly available in the UK, which are not prohibited by the United Nations Drug Convention but which may pose a public health threat comparable to that posed by substances listed in these conventions’ Leigh Westmore

 NPS are a global issue, fast adapting market  UNDOC identified 70 countries reporting NPS emerging in their drug markets ◦ Role of the internet creating a Global Market Place ◦ The Dark web  EMCDDA’s Early Warning System (EWS) was set up to ID new substances; o 81 novel NPS detected in 2013, an increase from 74 in 2012, 49 in 2011 and 41 in 2010 (96 already this year)  Largest group are the Synthetic Cannabinoid receptor agonists (SCRAs) Leigh Westmore

 UK set up its own Forensic Early Warning System (FEWS)  Since Novel NPS been seen. 10 SCRAs  Samples analysed contain mixture of substances  Analysis of NPS samples collected by FEWS found 9 out of 10 contained either two (61%) or three (30) active compounds  2013/2014 3% of internet and 4.3% of headshop samples contained Controlled NPS.  festival samples contained controlled NPS  Harmful or ineffective NPS removed from circulation by self regulatory market.  Of the 81 NPS reported in were only found in one EU state. #96 substances this year 2014 Leigh Westmore

 Studies have shown that there are three primary sources of NPS purchasing. ◦ Internet, High street retailers, Non retail vendors/family friends, street dealers ◦ Only 6% bought NPS online form a study of year olds in Most Common Source is from Friends  It is unclear how much the internet plays in NPS distribution. ◦ EU 651 online stores 150 “clearnet” in UK  Stores adhere to regulation (remove illicit or dangerous compounds) ◦ UK has 250+ headshops and other outlets ◦ Bulk Purchases distributed down from China and India Leigh Westmore

 Motivations for use. - Similar to illicit  Influenced by price, purity, availability, effects and legality.  Lack Purity of illicit substances  Sub Groups of users ◦ Gay men ◦ Professionals/Military ◦ Prisoners/those in touch with Criminal justice ◦ Psychonaughts ◦ Under 18’s ◦ Rural communities Leigh Westmore

 Early Detection – FEWS 2011 ◦ Forensic Support to Law enforcement, via testing seizures and samples etc  Data Collection and sharing – Drugs Early Warning System (DEWS) 2012 ◦ Collects and shares data at local national and international levels.  Legislation – MDA 1971 banned families of drugs. ◦ Controlled 550 substances since 2009 ◦ Stopped future modifications to an extent  Alternative Legislation – Intoxicating substances act ◦ GPSRs  Awareness Campaigns – Talk to Frank etc.. Leigh Westmore

 Five Approaches explored by expert panel. ◦ Analogue Approach ◦ Neurochemical approach ◦ Full regulatory approach ◦ Restricted Availability approach ◦ General prohibition on distribution  Positives and negatives looked at from angles Supply Demand Harm Enforcement Forensic science Legal services Costs communications Leigh Westmore

Concept Controls substances based on their chemical similarity to already controlled substances.  Pros ◦ Deterrent effect on producers and suppliers ◦ Successful legal prosecutions ◦ Reduce harms ◦ Prohibits huge range of substances  Cons ◦ Development of new drugs ◦ Increase crime through under ground networks displace to online sales – will people stop using? ◦ Very costly to enforce legally ◦ New drugs new harms and risk to users  Conclusion ◦ Would require significant investment ◦ Would not reduce overall prevalence of NPS Leigh Westmore

Principle Control drugs based on their effect on the brain, not just structure. Primary method for controlling SCRAs.  Pros ◦ Products removed from the shelves ◦ Legislation will catch up and over take SCRA synthesis and design ◦ Successful in USA/lux prosecutions introduced in 2012 ◦ People using herbal Cannabis less harmful!  Cons ◦ Very scientific (endocannabinoids) ◦ Costly in setting up ◦ Displacement to other NPS ◦ development of other novel NPS ◦ Not repeated everywhere buy online (Europe) ◦ Impact on legitimate pharmaceutical research  Conclusion ◦ Offers more certain legalities of control ◦ Needs careful Pragmatic introduction alongside analogue approach. Leigh Westmore

Concept Restricts NPS products and only allows those deemed ‘low risk’. Manufacturers have to fund testing to prove safety. Pros  Responsible retailing, moves away from harmful NPS. Information can be given freely.  Financial – taxation  Users of illicit and alcohol switch to “safe” NPS Cons  Potential black market NPS  Development of more NPS  Who and how do we define Low risk?  Confusing message that drug use safe? Conclusion  Could work well  Initially 47 licences granted all removed in April 2014 until full testing is completed. Leigh Westmore

Concept Open sale of all non-controlled NPS; labelling, no advertising and amounts rigorously controlled. Only sold in sex or betting shops with special licence’s. Class D drugs. (BZP) 2005 Pros  Restricted supply, reduced burden on law enforcement, harm reduction advice given at sale, Finances itself through licences and tax Cons  Profile of NPS on high streets would remain  People think they are still safe?  Compliance issues, local authorities would have to enforce Licences Conclusion  General public may not approve?  Political opposition  NPS would continue to develop Leigh Westmore

Concept Legislation prohibits supply, importation of an NPS not currently controlled regardless if its “not for human consumption” Can exclude simple possession or peer supply. Targets particular groups of non-criminal users. Does not have to cause harm. Pros  Headshop trade will disappear NPS notoriety diminish  Development of NPS will decrease  Reduction in use of those buying due to law  Cost effective cheap to do in comparison Cons  Underground trade, criminal gangs  Return to illicit drugs and prescription medication  No honest harm reduction  Difficult to prosecute unknown compounds  Increased pressure on Legal system to prosecute  Loss of tax Conclusions  Recommended, stops the evolution of NPS, reduces availability  Banning all sales could be seen as a disproportionate response as some substances have little or no risk  Careful definitions and exemptions need to be explored Leigh Westmore

The report concluded  There is no “silver bullet approach”  NPS situation cannot be resolved but its nature can be changed  The Main Residual challenge will be to continue to manage the criminal market  Recommendations should be developed along side systems and knowledge already in place for illicit substances not in isolation. Leigh Westmore

 Full Report response-to-expert-panel-report-on-the- new-psychoactive-substances-review   Leigh Westmore

  With Thanks – Rick Bradley Kent Young Person Services Leigh Westmore